Vitamin D Not Associated With Risk For Less Common Cancers, Study Finds
ASCO Recommends Aromatase Inhibitors As Adjuvant For Some Breast Cancer
Half Of Women Complete Full Hormone Therapy Regimen
Surveillance Colonoscopy Cost-Effective For High-Risk
Surveillance Treatment Option For Low-Risk Prostate Cancer
Toxicity, Non-Cancer Deaths Increase With Combo Therapy
Time Spent Sitting Associated With Total Mortality, Study Finds
Cancer Mortality Rate Down 1.3 Percent, ACS Report Finds
NCI-Approved Clinical Trials
Trending Stories
- Karen Knudsen to leave ACS
- A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease
- Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis shows
Subgroup analysis suggests risk of secondary cancers after CAR T-cell therapy is similar to risk after other therapies - Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72
- Mace Rothenberg’s museum will tell the stories behind breakthroughs in medicine
- Melanoma investigators invite FDA to publicly discuss approval endpoints and crossover design
The agency accepts the invitation
